Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania

MLA

Ayat H. Bakr, et al. “Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania.” Sudan Journal of Medical Sciences, vol. 14, Sept. 2019, pp. 1–6. EBSCOhost, https://doi.org/10.18502/sjms.v14i3.5208.

APA

Ayat H. Bakr, Abugroun E. A., AbdElkarim A. Abdrabo, Omeyma A. Mohamed, Mokhtar M. A., & GadAllah Modawe. (2019). Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania. Sudan Journal of Medical Sciences, 14, 1–6. https://doi.org/10.18502/sjms.v14i3.5208

Chicago

Ayat H. Bakr, Abugroun E. A., AbdElkarim A. Abdrabo, Omeyma A. Mohamed, Mokhtar M. A., and GadAllah Modawe. 2019. “Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania.” Sudan Journal of Medical Sciences 14 (September): 1–6. doi:10.18502/sjms.v14i3.5208.